Caribou Biosciences, Inc. (CRBU) vs NRx Pharmaceuticals, Inc. (NRXP)
Caribou Biosciences, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($134.0M and $131.2M). NRx Pharmaceuticals, Inc. has the higher net margin (−691.8% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, NRx Pharmaceuticals, Inc. leads on 9 and Caribou Biosciences, Inc. on 5.
Valuation
Profitability
| Metric | CRBU | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 46.64% | 65.16% |
| Operating margin | (1,090.90%) | (586.15%) | 0.00% |
| Net margin | (1,030.42%) | (691.78%) | 0.00% |
| Free cash flow margin | (1,323.30%) | (609.02%) | 0.00% |
| Return on equity | (78.27%) | 131.22% | (57.72%) |
| Return on assets | (56.87%) | (120.41%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack